Glaxosmithkline Pharmaceuticals Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

38 Stocks to buy right now

Join now and be among the first to discover Stock Ideas

Get the Stocks!

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1924

Chairman: R S Karnad

Managing Director: A Vaidheesh

Group: Glaxosmithkline - MNC

Listing: NSE: GLAXO, BSE: 500660

Headquarters: Mumbai, Maharashtra

Website: www.gsk-india.com

Key Facts

Market cap: R 28,592.35 Cr

Revenue (TTM): R 3,246.69 Cr

Earnings (TTM): R 852.25 Cr

Cash: R 1,171.35 Cr

Total Debt: R 0.58 Cr

Promoters' ownership: 75.00%

Liquidity: High

52 Week range: R 1,130.00 - 1,737.00

Face value: R10.00

Shares outstanding: 16,94,06,034

Stock Performance

Trailing
Annual

Time Period	Glaxosmithkline Pharma	S&P BSE Mid Cap	S&P BSE Healthcare
YTD	4.73	4.74	6.31
1 month	4.23	5.01	6.41
3 months	8.73	8.56	9.95
1 Year	21.09	8.79	4.53
3 Years	7.12	6.53	-1.59
5 Years	-0.10	7.72	-1.73
10 Years	8.25	9.29	11.62

As on 28-Jan-2020

Year	Glaxosmithkline Pharma	S&P BSE Mid Cap	S&P BSE Healthcare
2019	7.50	-3.05	-3.55
2018	21.62	-13.31	-5.89
2017	-8.81	48.13	0.49
2016	-17.15	7.97	-12.88
2015	4.55	7.43	15.06
2014	6.96	54.69	47.43
2013	39.74	-5.73	22.55

Annual Report (FY18)

Review & Analysis

Decoding capital expenditure
Research Desk . 08-Nov-2018
The quest for value
Mohammed Ekramul Haque . 20-Oct-2015
Pedigree in Lifestyle
Research Desk . 13-Sep-2012
Living The Larger Life
Research Desk . 22-Apr-2009
In The Pink Of Health
Research Desk . 20-May-2008

News & Announcements